lcerative colitis- real world study for the effects of biologics, anti-TNF alpha- golimumab in remission- induction and maintenance- (UC- BINGO) study
Not Applicable
Recruiting
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000026844
- Lead Sponsor
- Saitama Medical University, Saitama Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who has contraindication of golimumab Patients in pregnancy and lactation period Patients who has and had malignancy Patients who don nott have informed conents Patients determined not to be suitable for this study by physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical response rate at week 6
- Secondary Outcome Measures
Name Time Method